Jin Medical International Ltd. — Form SCHEDULE 13D/A
Filed September 25, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Jin Medical International Ltd. filed a Schedule 13D/A (amended beneficial ownership statement) on 2026-09-25. The filing header provides company and filer information but does not display the substantive amendment details (share count, percentage ownership, transaction details, or counterparty information) needed to assess the change. Without access to the full document body, specific dollar amounts, share counts, ownership percentages, and the nature of the ownership change cannot be determined.
Why this rating
Schedule 13D/A amendments are routine disclosure updates. Without visible substantive details (shares, %, counterparty, consideration), cannot assess materiality to $53.4M company. Standard filing.
See more from September 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.